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Abstract
As emergency medicine physicians, we have formulated an approach to managing patients with
a chief complaint of headache that starts with considering the story the patient relays in the
context of a wide differential. Here we will describe a case that presented to our emergency
department in hopes to broaden your differential. Reversible cerebral vasoconstriction
syndrome (RCVS), well described in the neurology literature, is characterized by severe
headaches that may or may not be accompanied by neurological symptoms and is definitively
diagnosed by diffuse constriction of cerebral arteries on cerebral angiogram. Here we present a
case of a patient who presented to the emergency department with intermittent severe
persistant headaches and was diagnosed with reversible cerebral vasoconstriction syndrome.
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Introduction

Received 04/10/2018
Review began 04/12/2018
Review ended 04/13/2018

Reversible cerebral vasoconstriction syndrome (RCVS) is a recognized syndrome within the
neurology and cerebrovascular community. Our goal with this case report is to bring it to the
attention of the emergency medicine community as well. The clinical presentation of this
syndrome is “sudden onset and severe headaches over one to three weeks, often accompanied
by nausea, vomiting, photophobia, confusion, and blurred vision” [1]. Definitive diagnosis
requires a cerebral angiogram showing the characteristic “string of beads” [1], which
demonstrates the diffuse vasoconstriction of the cerebral arteries. The treatments proposed by
various sources have not shown to prevent the more significant ischemic or hemorrhagic
complications, although there is a lack of randomized control trials in this area [1]. The case we
present here was one that we found perplexing and resulted in this diagnosis, which we had no
prior education on.

Published 04/16/2018
© Copyright 2018
Buttar et al. This is an open access
article distributed under the terms of
the Creative Commons Attribution
License CC-BY 3.0., which permits
unrestricted use, distribution, and
reproduction in any medium,
provided the original author and
source are credited.

Case Presentation
A 49-year-old woman with a past medical history of hypertension, preeclampsia, anxiety, and
bipolar disorder on buspirone, presented to the emergency department with triage complaint
of “multiple complaints”. Her history of present illness revealed a persistent headache that
initially started one week prior to arrival. The patient recalled onset in the evening associated
with nausea and vomiting. She went to an urgent care the next day and received medications,
after which she felt better for about two days. When her symptoms recurred, she went to an
outside hospital where she had a computed tomography scan of the head and lumbar puncture,
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both of which were negative. The patient was admitted for an elevated troponin level and
received a cardiac catheterization without intervention, findings significant for 60% blockage
of a single vessel. The patient presented to us one day post discharge due to persistent
headache. She described the headache as similar to her prior preeclampsia headache, feeling
"like a grip around" her entire head.
Her initial vital signs were as follows: blood pressure 172/92 mmHg, pulse 81, respiratory rate
18, and oxygen saturation 99% on room air. A physical exam revealed a woman in pain but
nontoxic appearing. Her heart and lung sounds were normal. Her neurological exam was
unremarkable with no focal numbness, weakness, or abnormalities with coordination, gait, or
cranial nerves. The chest plain film, initial lab, and electrocardiogram results were normal.
The patient received one liter intravenous fluids, metoclopramide intravenous, and ketorolac
intravenous with minimal improvement and still appeared uncomfortable on multiple
reassessments. The patient was placed in the observation unit and a magnetic resonance
imaging (MRI) of the brain was ordered.
The magnetic resonance imaging (MRI) of the brain showed three punctate regions of focal
restricted diffusion in the left middle frontal gyrus, right parietal lobe, and left temporal lobe
that appeared consistent with acute infarcts. The image is provided below (Figure 1).
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FIGURE 1: Magnetic Resonance Imaging Brain Noncontrast
This image demonstrates two regions of focal restricted diffusion in the right parietal lobe and
the left temporal lobe, which represent acute embolic infarcts.

Neurology was consulted and the patient was admitted to the stroke service. Her stroke workup,
which included computed tomography angiography of the head and neck, transthoracic
echocardiogram, and a transesophageal echocardiogram, was unremarkable. The differential at
that point was narrowed down to vasculitis versus RCVS as the cause of the severe headache
associated with acute infarction. Neurosurgery was consulted and an angiogram was
performed, showing evidence of RCVS in the middle cerebral artery, M1 segment, and distal
middle cerebral artery territories as well as the right posterior cerebral artery and distal
anterior cerebral artery. Dual antiplatelet therapy with aspirin and clopidogrel was initiated
and the patient was discharged to follow up with the stroke clinic and her primary care
provider.

2018 Buttar et al. Cureus 10(4): e2487. DOI 10.7759/cureus.2487

3 of 5

Discussion
Reversible cerebral vasoconstriction disorder is becoming increasingly prominent as an
interesting and more common than previously suggested diagnosis in the neurology literature.
The etiology of this syndrome is thought to be due to a “disturbance in the control of
cerebrovascular tone” [2]. It is difficult to make this diagnosis because of the transitory nature
of findings on radiology studies. Initial negative brain imaging studies followed by an evidence
of brain ischemia or hemorrhage found on subsequent imaging a few days later, as observed in
this case, is the classic presentation of this syndrome [2]. The main diagnoses to exclude when
considering RCVS in the differential are subarachnoid hemorrhage and vasculitis [3].
The majority of the cases of RCVS are patients who are either postpartum or on vasoactive
drugs. The three patients Singhal et al. described who developed “thunderclap headache,
reversible cerebral arterial vasoconstriction, and ischemic stroke” were all exposed to
serotonin-enhancing drugs, which are thought to cause “reversible, multifocal arterial
narrowing” [4]. In their analysis of 139 cases of RCVS, Singhal et al. found that 42% were
exposed to vasoactive drugs such as cannabis, cocaine, amphetamines, selective serotonin
reuptake inhibitors, and alpha sympathomimetics [5]. Our patient, in this case, was on
buspirone, which is an agonist at serotonergic receptors. In RCVS, intracranial hemorrhage is
frequent [6]. Women and patients with a history of migraines appear to be more at risk for
intracranial hemorrhage in those with RCVS [6].
Little is known about the treatment of this condition. Both Ducros et al. and Singhal et al. have
considered nimodipine in the treatment of the headaches associated with RCVS. There is
currently no randomized control trial that has explored this treatment option and further
research must be done to find a suitable therapy [2].

Conclusions
As emergency medicine physicians, it is our responsibility to continually expand our
differential for common chief complaints. Whether or not to include reversible cerebral
vasoconstriction disorder in our differential for the patient with headache is something that
warrants discussion. RCVS should be suspected in patients with recurrent thunderclap
headaches, particularly in the setting of vasoactive drug use or postpartum state. Including
RCVS in the differential for patients with recurrent headaches with vague neurological
complaints is important in establishing their diagnosis and managing their symptoms. While
the pathological process, definitive diagnosis, and treatment remain unclear, considering the
diagnosis is an important first step in the care of these patients.
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